Brief: PMV Pharma Reports FY22 Financial Results And Corporate Highlights
March 1 (Reuters) - PMV Pharmaceuticals Inc PMVP.O :
* PMV PHARMACEUTICALS REPORTS FULL YEAR 2022 FINANCIAL
RESULTS AND
CORPORATE HIGHLIGHTS
* PMV PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS, AND
MARKETABLE
SECURITIES OF $243.5 MILLION AS OF DECEMBER 31, 2022
Source text for Eikon: ID:nGNXbXb0qF
Further company coverage: PMVP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics